- Home
- CDTX vs ARI Comparison
CDTX vs ARI Comparison
Compare CDTX & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- ARI
- Stock Information
- Founded
- CDTX 2012
- ARI 2009
- Country
- CDTX United States
- ARI United States
- Employees
- CDTX 73
- ARI N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ARI Real Estate Investment Trusts
- Sector
- CDTX Health Care
- ARI Real Estate
- Exchange
- CDTX Nasdaq
- ARI Nasdaq
- Market Cap
- CDTX 1.6B
- ARI 1.5B
- IPO Year
- CDTX 2015
- ARI 2009
- Fundamental
- Price
- CDTX $65.32
- ARI $10.86
- Analyst Decision
- CDTX Strong Buy
- ARI Hold
- Analyst Count
- CDTX 11
- ARI 4
- Target Price
- CDTX $57.00
- ARI $10.08
- AVG Volume (30 Days)
- CDTX 489.9K
- ARI 703.8K
- Earning Date
- CDTX 11-06-2025
- ARI 10-29-2025
- Dividend Yield
- CDTX N/A
- ARI 9.07%
- EPS Growth
- CDTX N/A
- ARI N/A
- EPS
- CDTX N/A
- ARI N/A
- Revenue
- CDTX N/A
- ARI $273,783,000.00
- Revenue This Year
- CDTX N/A
- ARI $26.08
- Revenue Next Year
- CDTX N/A
- ARI $18.31
- P/E Ratio
- CDTX N/A
- ARI N/A
- Revenue Growth
- CDTX N/A
- ARI 55.89
- 52 Week Low
- CDTX $10.14
- ARI $7.70
- 52 Week High
- CDTX $69.36
- ARI $11.11
- Technical
- Relative Strength Index (RSI)
- CDTX 58.07
- ARI 64.53
- Support Level
- CDTX $61.10
- ARI $10.42
- Resistance Level
- CDTX $65.84
- ARI $11.11
- Average True Range (ATR)
- CDTX 3.05
- ARI 0.15
- MACD
- CDTX -0.42
- ARI 0.03
- Stochastic Oscillator
- CDTX 71.23
- ARI 70.79
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.